Key points are not available for this paper at this time.
Benefits and limitations in using NCCN guidelines to distinguish TP53 CH from mosaic LFS.
Nathan et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: